Literature DB >> 19621458

Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.

Kawsar R Talaat1, Jennifer A Rothman, Jeffrey I Cohen, Mariarita Santi, John K Choi, Miguel Guzman, Robert Zimmerman, Sudha Nallasamy, Alexander Brucker, Martha Quezado, Stefania Pittaluga, Nicholas J Patronas, Amy D Klion, Kim E Nichols.   

Abstract

X-linked lymphoproliferative disease (XLP) is an immunodeficiency caused by defects in the adaptor molecule SAP. The manifestations of XLP generally occur following Epstein-Barr virus (EBV) infection and include fulminant mononucleosis, hypogammaglobulinemia and lymphoma. In this report, we describe two unrelated patients with fatal T-cell-mediated central nervous system vasculitis for whom repeated serologic and molecular testing for EBV was negative. In both patients, clonal T-cell populations were observed, but neither demonstrated evidence of lymphoma. Thus, loss of SAP function can lead to dysregulated immune responses characterized by the uncontrolled expansion and activation of T cells independent of EBV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621458      PMCID: PMC2745493          DOI: 10.1002/pbc.22185

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  20 in total

1.  Giant cell arteritis after influenza vaccination.

Authors:  C Perez; E Loza; T Tinture
Journal:  Arch Intern Med       Date:  2000-09-25

2.  Epstein-Barr virus-related bilateral acute retinal necrosis in a patient with X-linked lymphoproliferative disorder.

Authors:  Vrinda S Hershberger; Robert K Hutchins; David P Witte; Susan Schneider; Richard E Harris; Shane J McGonegle
Journal:  Arch Ophthalmol       Date:  2003-07

3.  Lymphocytic vasculitis in X-linked lymphoproliferative disease.

Authors:  J P Dutz; L Benoit; X Wang; D J Demetrick; A Junker; D de Sa; R Tan
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

4.  Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.

Authors:  S Loeffel; C H Chang; R Heyn; S Harada; H Lipscomb; F Sinangil; D J Volsky; K McClain; H Ochs; D T Purtilo
Journal:  Arch Pathol Lab Med       Date:  1985-06       Impact factor: 5.534

5.  Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases.

Authors:  A Zaas; P Scheel; A Venbrux; D B Hellmann
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

6.  Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.

Authors:  Elizabeth M Begier; Carol A Langford; Michael C Sneller; Robert P Wise; Robert Ball
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

7.  Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.

Authors:  H U Simon; S G Plötz; R Dummer; K Blaser
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

8.  [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].

Authors:  C Grosieux; J C Amoric; F Mechinaud; A Moreau; J M Mussini; H Fesneau; B Dreno; B Bureau; J F Stalder; P Litoux
Journal:  Ann Dermatol Venereol       Date:  1996       Impact factor: 0.777

9.  Retinal necrosis in X-linked lymphoproliferative disease.

Authors:  H E Grossniklaus; T M Aaberg; E W Purnell; J Luka; T A Seemayer
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

Review 10.  Vaccines and Guillain-Barré syndrome.

Authors:  Penina Haber; James Sejvar; Yann Mikaeloff; Frank DeStefano
Journal:  Drug Saf       Date:  2009       Impact factor: 5.228

View more
  13 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.

Authors:  Paul E Gray; Tracey A O'Brien; Mayura Wagle; Stuart G Tangye; Umaimainthan Palendira; Tony Roscioli; Sharon Choo; Rosemary Sutton; John B Ziegler; Katie Frith
Journal:  J Clin Immunol       Date:  2015-10-03       Impact factor: 8.317

3.  Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.

Authors:  Rebecca A Marsh; Jack J Bleesing; Alexandra H Filipovich
Journal:  J Immunol Methods       Date:  2010-09-09       Impact factor: 2.303

Review 4.  X-linked lymphoproliferative syndromes: brothers or distant cousins?

Authors:  Alexandra H Filipovich; Kejian Zhang; Andrew L Snow; Rebecca A Marsh
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

Review 5.  Primary immunodeficiency diseases associated with neurologic manifestations.

Authors:  Soodabeh Fazeli Dehkordy; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2011-10-26       Impact factor: 8.542

Review 6.  X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.

Authors:  Neelam Panchal; Claire Booth; Jennifer L Cannons; Pamela L Schwartzberg
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 7.  Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.

Authors:  Sylvain Latour; Sarah Winter
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

8.  Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease.

Authors:  Jia Zhu; Yu Zhang; Zi-Jun Zhen; Yan Chen; Juan Wang; Rui-Qing Cai; Xiao-Fei Sun
Journal:  Chin J Cancer       Date:  2013-07-02

9.  Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation.

Authors:  Dara McCreary; Ebun Omoyinmi; Ying Hong; Ciara Mulhern; Charalampia Papadopoulou; Marina Casimir; Yael Hacohen; Rodney Nyanhete; Helena Ahlfors; Thomas Cullup; Ming Lim; Kimberly Gilmour; Kshitij Mankad; Evangeline Wassmer; Stefan Berg; Cheryl Hemingway; Paul Brogan; Despina Eleftheriou
Journal:  JAMA Netw Open       Date:  2019-10-02

10.  X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.

Authors:  Tao Xu; Qin Zhao; Wenyan Li; Xuemei Chen; Xiuhong Xue; Zhi Chen; Xiao Du; Xiaoming Bai; Qian Zhao; Lina Zhou; Xuemei Tang; Xi Yang; Hirokazu Kanegane; Xiaodong Zhao
Journal:  Eur J Pediatr       Date:  2019-11-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.